BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11555587)

  • 1. Clinical characteristics of prostate cancer in an analysis of linkage to four putative susceptibility loci.
    Goode EL; Stanford JL; Peters MA; Janer M; Gibbs M; Kolb S; Badzioch MD; Hood L; Ostrander EA; Jarvik GP
    Clin Cancer Res; 2001 Sep; 7(9):2739-49. PubMed ID: 11555587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCAP is the major known prostate cancer predisposing locus in families from south and west Europe.
    Cancel-Tassin G; Latil A; Valéri A; Mangin P; Fournier G; Berthon P; Cussenot O
    Eur J Hum Genet; 2001 Feb; 9(2):135-42. PubMed ID: 11313747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease.
    Schleutker J; Matikainen M; Smith J; Koivisto P; Baffoe-Bonnie A; Kainu T; Gillanders E; Sankila R; Pukkala E; Carpten J; Stephan D; Tammela T; Brownstein M; Bailey-Wilson J; Trent J; Kallioniemi OP
    Clin Cancer Res; 2000 Dec; 6(12):4810-5. PubMed ID: 11156239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study.
    Cunningham JM; McDonnell SK; Marks A; Hebbring S; Anderson SA; Peterson BJ; Slager S; French A; Blute ML; Schaid DJ; Thibodeau SN;
    Prostate; 2003 Dec; 57(4):335-46. PubMed ID: 14601030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX.
    Lange EM; Chen H; Brierley K; Perrone EE; Bock CH; Gillanders E; Ray ME; Cooney KA
    Clin Cancer Res; 1999 Dec; 5(12):4013-20. PubMed ID: 10632333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families.
    Xu J; Gillanders EM; Isaacs SD; Chang BL; Wiley KE; Zheng SL; Jones M; Gildea D; Riedesel E; Albertus J; Freas-Lutz D; Markey C; Meyers DA; Walsh PC; Trent JM; Isaacs WB
    Prostate; 2003 Dec; 57(4):320-5. PubMed ID: 14601028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1.
    Grönberg H; Xu J; Smith JR; Carpten JD; Isaacs SD; Freije D; Bova GS; Danber JE; Bergh A; Walsh PC; Collins FS; Trent JM; Meyers DA; Isaacs WB
    Cancer Res; 1997 Nov; 57(21):4707-9. PubMed ID: 9354426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confirmation of the prostate cancer susceptibility locus HPCX in a set of 104 German prostate cancer families.
    Bochum S; Paiss T; Vogel W; Herkommer K; Hautmann R; Haeussler J
    Prostate; 2002 Jun; 52(1):12-9. PubMed ID: 11992616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer.
    Berry R; Schaid DJ; Smith JR; French AJ; Schroeder JJ; McDonnell SK; Peterson BJ; Wang ZY; Carpten JD; Roberts SG; Tester DJ; Blute ML; Trent JM; Thibodeau SN
    Am J Hum Genet; 2000 Feb; 66(2):539-46. PubMed ID: 10677314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No evidence of linkage to chromosome 1q42.2-43 in 131 prostate cancer families from the ACTANE consortium. Anglo, Canada, Texas, Australia, Norway, EU Biomed.
    Singh R;
    Br J Cancer; 2000 Dec; 83(12):1654-8. PubMed ID: 11104562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic analysis of familial prostatic cancer: localization of a gene predisposing to prostatic cancer (PCaP) on chromosome 1q 42.2-43].
    Valeri A; Drelon E; Paiss T; Vogel W; de Petriconi R; Hautmann R; Fournier G; Mangin P; Berthon P; Cussenot O
    Prog Urol; 1999 Sep; 9(4):680-8. PubMed ID: 10555221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-26.
    Schleutker J; Baffoe-Bonnie AB; Gillanders E; Kainu T; Jones MP; Freas-Lutz D; Markey C; Gildea D; Riedesel E; Albertus J; Gibbs KD; Matikainen M; Koivisto PA; Tammela T; Bailey-Wilson JE; Trent JM; Kallioniemi OP
    Prostate; 2003 Dec; 57(4):280-9. PubMed ID: 14601024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a prostate cancer susceptibility locus on the X chromosome.
    Xu J; Meyers D; Freije D; Isaacs S; Wiley K; Nusskern D; Ewing C; Wilkens E; Bujnovszky P; Bova GS; Walsh P; Isaacs W; Schleutker J; Matikainen M; Tammela T; Visakorpi T; Kallioniemi OP; Berry R; Schaid D; French A; McDonnell S; Schroeder J; Blute M; Thibodeau S; Grönberg H; Emanuelsson M; Damber JE; Bergh A; Jonsson BA; Smith J; Bailey-Wilson J; Carpten J; Stephan D; Gillanders E; Amundson I; Kainu T; Freas-Lutz D; Baffoe-Bonnie A; Van Aucken A; Sood R; Collins F; Brownstein M; Trent J
    Nat Genet; 1998 Oct; 20(2):175-9. PubMed ID: 9771711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complex genetic epidemiology of prostate cancer.
    Schaid DJ
    Hum Mol Genet; 2004 Apr; 13 Spec No 1():R103-21. PubMed ID: 14749351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortium.
    Edwards S; Meitz J; Eles R; Evans C; Easton D; Hopper J; Giles G; Foulkes WD; Narod S; Simard J; Badzioch M; Mahle L;
    Prostate; 2003 Dec; 57(4):270-9. PubMed ID: 14601023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suggestive linkage of familial primary cutaneous amyloidosis to a locus on chromosome 1q23.
    Lin MW; Lee DD; Lin CH; Huang CY; Wong CK; Chang YT; Liu HN; Hsiao KJ; Tsai SF
    Br J Dermatol; 2005 Jan; 152(1):29-36. PubMed ID: 15656797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suggestive genetic linkage to chromosome 11p11.2-q12.2 in hereditary prostate cancer families with primary kidney cancer.
    Johanneson B; Deutsch K; McIntosh L; Friedrichsen-Karyadi DM; Janer M; Kwon EM; Iwasaki L; Hood L; Ostrander EA; Stanford JL
    Prostate; 2007 May; 67(7):732-42. PubMed ID: 17372923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci.
    Witte JS; Suarez BK; Thiel B; Lin J; Yu A; Banerjee TK; Burmester JK; Casey G; Catalona WJ
    Prostate; 2003 Dec; 57(4):298-308. PubMed ID: 14601026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of HPC1, HPCX, and PCaP in Icelandic hereditary prostate cancer.
    Bergthorsson JT; Johannesdottir G; Arason A; Benediktsdottir KR; Agnarsson BA; Bailey-Wilson JE; Gillanders E; Smith J; Trent J; Barkardottir RB
    Hum Genet; 2000 Oct; 107(4):372-5. PubMed ID: 11129338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide linkage analysis for aggressive prostate cancer in Utah high-risk pedigrees.
    Christensen GB; Camp NJ; Farnham JM; Cannon-Albright LA
    Prostate; 2007 May; 67(6):605-13. PubMed ID: 17299800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.